Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Allurion Technologies (ALUR) Net Income towards Common Stockholders (2022 - 2025)

Allurion Technologies (ALUR) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with -$11.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 31.99% year-over-year to -$11.9 million, compared with a TTM value of -$48.6 million through Sep 2025, down 71.32%, and an annual FY2024 reading of -$26.1 million, up 68.23% over the prior year.
  • Net Income towards Common Stockholders was -$11.9 million for Q3 2025 at Allurion Technologies, down from -$9.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.0 million in Q1 2024 and bottomed at -$28.6 million in Q4 2024.
  • Average Net Income towards Common Stockholders over 4 years is -$12.2 million, with a median of -$12.0 million recorded in 2022.
  • The sharpest move saw Net Income towards Common Stockholders surged 110.78% in 2024, then plummeted 331.78% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at -$13.1 million in 2022, then crashed by 46.64% to -$19.2 million in 2023, then plummeted by 48.89% to -$28.6 million in 2024, then soared by 58.39% to -$11.9 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for ALUR at -$11.9 million in Q3 2025, -$9.3 million in Q2 2025, and $1.2 million in Q1 2025.